Product: | Adenosine-13C10,15N5 | ||||
---|---|---|---|---|---|
Catalog Number: | CN4080 | ||||
Synonyms: | rA-13C1015N5 | ||||
Pricing: |
|
||||
Enrichment: | 13C>98%,15N>98% | ||||
Molecular Weight: | 300.15 | ||||
Structure: |
![]() |
||||
Category: | Ribonucleosides- Double Labeled with 13C,15N | ||||
Literature References: |
Costa, F; Biaggioni, I., Role of nitric oxide in adenosine-induced vasodilation in humans. Hypertension, 1998, May, 31(5): 1061–4.; Morgan, JM; McCormack, DG; Griffiths, MJ; Morgan, CJ; Barnes, PJ; Evans, TW, Adenosine as a vasodilator in primary pulmonary hypertension.Circulation, 1991, Sept., 84(3): 1145–9.; Sato, A., Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. American journal of physiology. Heart and circulatory physiology, 2005, April, 288(4): H1633–40. |
||||
MSDS: | |||||
Description: | The labeled purine nucleoside compound composed of a molecule of adenine bonded to a ribose molecule. | ||||
Applications: | Plays an important role in energy transfer as ATP and ADP as well as in transduction as cAMP. It is also a neuromodulator that helps promote sleep and suppress arousal. Also regulates blood flow through vasodilation. Used as a medication to treat some forms of supraventricular tachycardia as an antiarrhythmic agent. |